Brain Activation Pattern Caused by Immersive Virtual Reality Pathfinding Task in Stroke Patients: an FNIRS Study
Launched by DINGQUN BAI · Nov 21, 2024
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how the brain responds to a special task using virtual reality in patients who have had a stroke. Researchers want to understand how these patients think and process information while doing a virtual pathfinding task, which involves navigating through a computer-generated environment. By observing brain activity during this task, the study aims to learn more about cognitive decline in stroke patients and how immersive experiences might help.
To participate in the trial, you must be between 18 and 80 years old and have had a stroke confirmed by brain imaging, like a CT or MRI scan. You should also be able to follow instructions and complete the tasks set by the researchers. Healthy individuals who meet similar age criteria and are not taking any medications may also be eligible. Participants will take part in the virtual reality task while their brain activity is monitored. It’s important to note that those with certain health issues, serious mental illnesses, or specific medical histories may not be able to participate. If you're interested, you will need to sign an informed consent form to confirm your willingness to join the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Stroke patients:
- • 1. Diagnosis of stroke confirmed by neuroimaging (CT or MRI)
- • 2. 18-80 years old
- • 3. Able to complete the cognitive task
- • 4. Able to follow instructions to complete the trial
- • 5. Patients who signed an informed consent form.
- Healthy Subjects:
- • 1. No abnormalities on cranial
- • 2. 18-80 years old
- • 3. Able to complete cognitive task
- • 4. Able to follow instructions to complete the trial
- • 5. not taking medications.
- • 6. Subjects who signed an informed consent form.
- Exclusion Criteria:
- Stroke patients:
- • 1. Inability to tolerate the test due to organic diseases
- • 2. Serious mental illness that prevents them from cooperating with or tolerating the trial
- • 3. Pregnant or lactating women
- • 4. Had metal implants, a history of other neurological disorders, acute cardiopulmonary dysfunction.
- Healthy Subjects:
- • 1. Inability to tolerate the test due to organic diseases
- • 2. Serious mental illness that prevents them from cooperating with or tolerating the trial.
- • 3. Pregnant or lactating women
- • 4. Had metal implants, a history of other neurological disorders, acute cardiopulmonary dysfunction
About Dingqun Bai
Dingqun Bai is a dedicated clinical trial sponsor focused on advancing innovative therapeutic solutions through rigorous research and development. With a commitment to enhancing patient outcomes, the organization collaborates with leading healthcare professionals and institutions to design and execute high-quality clinical trials. Dingqun Bai emphasizes scientific integrity and regulatory compliance, ensuring that all studies are conducted with the utmost attention to ethical standards and patient safety. Through its strategic approach and expertise, the sponsor aims to contribute significantly to the evolving landscape of medical treatments and improve healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chongqing, Chongqing, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported